Apramycin

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:Apramycin.png

Apramycin

Systematic (IUPAC) name
(2R,3R,4R,5S,6R)-5-amino-2-[((1R,2R,3R,4R,6R,8R)-
8-amino-9-[(1R,2S,3R,4R,6R)-4,6-diamino-
2,3-dihydroxy-cyclohexyl]oxy-2-hydroxy-
3-methylamino-5,10-dioxabicyclo[4.4.0]dec-4-yl)oxy]-
6-(hydroxymethyl)oxane-3,4-diol
Identifiers
PubChem         71428
Chemical data
Formula C21H41N5O11 
Molar mass 539.577
Complete data

WikiDoc Resources for

Apramycin

Articles

Most recent articles on Apramycin

Most cited articles on Apramycin

Review articles on Apramycin

Articles on Apramycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Apramycin

Images of Apramycin

Photos of Apramycin

Podcasts & MP3s on Apramycin

Videos on Apramycin

Evidence Based Medicine

Cochrane Collaboration on Apramycin

Bandolier on Apramycin

TRIP on Apramycin

Clinical Trials

Ongoing Trials on Apramycin at Clinical Trials.gov

Trial results on Apramycin

Clinical Trials on Apramycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Apramycin

NICE Guidance on Apramycin

NHS PRODIGY Guidance

FDA on Apramycin

CDC on Apramycin

Books

Books on Apramycin

News

Apramycin in the news

Be alerted to news on Apramycin

News trends on Apramycin

Commentary

Blogs on Apramycin

Definitions

Definitions of Apramycin

Patient Resources / Community

Patient resources on Apramycin

Discussion groups on Apramycin

Patient Handouts on Apramycin

Directions to Hospitals Treating Apramycin

Risk calculators and risk factors for Apramycin

Healthcare Provider Resources

Symptoms of Apramycin

Causes & Risk Factors for Apramycin

Diagnostic studies for Apramycin

Treatment of Apramycin

Continuing Medical Education (CME)

CME Programs on Apramycin

International

Apramycin en Espanol

Apramycin en Francais

Business

Apramycin in the Marketplace

Patents on Apramycin

Experimental / Informatics

List of terms related to Apramycin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Apramycin (also Nebramycin II) is an aminoglycoside antibiotic.



de:Apramycin



WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .